Today: 19 May 2026
FTSE 100 hits a fresh record as UK inflation cools — BAE, Glencore jump
18 February 2026
2 mins read

FTSE 100 hits a fresh record as UK inflation cools — BAE, Glencore jump

London, Feb 18, 2026, 14:00 GMT — Regular session

London’s FTSE 100 pushed higher again Wednesday, rising about 1% and hovering near its all-time highs as softer inflation numbers fueled fresh rate-cut wagers. The blue-chip index touched 10,666.68 during the session, last quoted near 10,660, after a record 10,556.17 close the previous day. BAE Systems stood out among defence names, surging, while Glencore advanced on news of a $2 billion payout. Raspberry Pi, meanwhile, kept its brisk rally alive.

Why this matters now: Policymakers are getting some relief as inflation heads lower. The UK’s consumer prices index (CPI) increased by 3.0% in the year to January, a drop from December’s 3.4%, according to the latest data. That’s shoring up hopes that price pressures are starting to cool.

Equity prices tend to react to rate expectations—cheaper borrowing often boosts valuations while giving households and businesses some breathing room. The Bank of England held its Bank Rate at 3.75% in the last meeting, but it was a narrow call; four policymakers argued for a cut. That split keeps traders on edge with every new inflation figure.

AJ Bell’s Russ Mould said, “This increases the chances of an interest rate cut when the Bank of England meets next month,” noting that’s “typically good news for stocks and shares in general.” Antofagasta topped the FTSE 100 leaderboard at midday. Diageo, though, trailed. London South East

Sterling held its ground after tumbling Tuesday, with traders still eyeing a possible rate cut in March. “Services CPI was a little bit higher than expected,” said Chris Turner, ING’s global head of research, noting the pound saw “a little bit of reprieve” on that. Turner also pointed to next week’s by-election, calling it a political risk that could shake both sterling and gilts if the result turns against the government. Reuters

Midcaps were also on the rise. The FTSE 250 climbed 0.24% to 23,611.77 points in delayed midday trading, staying close to the upper end of its latest range.

Global equities found support from improved risk sentiment. Investors stepped back from the recent AI-driven selling, giving European stocks room to notch fresh highs. Oil prices also bounced following a stretch of declines. Later, eyes shift to the Federal Reserve’s January meeting minutes.

The easing narrative isn’t without its complications. Analysts at the National Institute of Economic and Social Research argue the newest figures line up with a downward move in inflation, projecting CPI will hit the BoE’s 2% goal in the first half of the year. Still, markets appear to have already absorbed much of the optimism, and a fresh bout of stubborn domestic prices could easily rattle that outlook.

UK traders are eyeing a batch of local data next, as retail sales figures and preliminary PMI business surveys approach on the calendar.

March 19 looms larger—that’s when the Bank of England releases its rate call and minutes, making it the key event traders are watching for UK rate-cut signals.

Stock Market Today

  • When Will Island Pharmaceuticals Limited (ASX:ILA) Reach Profitability?
    May 19, 2026, 3:26 AM EDT. Island Pharmaceuticals Limited (ASX:ILA), a drug repurposing company focusing on antiviral therapeutics in Australia and the U.S., posted a AU$3.9 million loss in the latest financial year and a AU$7.2 million loss over the trailing twelve months. Analysts project the company will break even in 2027 and reach a profit of AU$295 million by 2028. This forecast implies an ambitious average annual growth rate of 140%. Notably, Island Pharmaceuticals operates with no debt, relying solely on shareholder funding, which reduces financial risk typical in cash-burning pharmaceutical firms. Investors anticipate milestone developments but should remain cautious of the high growth assumptions given the volatile nature of pharmaceutical cash flows during drug development phases.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Figma shares test rebound as AI bet delivers

Figma shares test rebound as AI bet delivers

18 May 2026
Figma traded at $23.20 Monday afternoon, valuing the company at $12.1 billion. First-quarter revenue jumped 46% to $333.4 million, and the company raised its 2026 revenue forecast to up to $1.428 billion. Paid customers rose 54% to about 690,000. Figma posted a GAAP net loss of $142.4 million but reported $56.5 million in non-GAAP net income.
Strike threat at Futamura: Wigton packaging workers reject 1.2% pay rise, set vote
Previous Story

Strike threat at Futamura: Wigton packaging workers reject 1.2% pay rise, set vote

British American Tobacco share price rises early as BAT reiterates 2026 outlook and keeps buyback running
Next Story

British American Tobacco share price rises early as BAT reiterates 2026 outlook and keeps buyback running

Go toTop